PLoS ONE (Jan 2011)

Defective CFTR-dependent CREB activation results in impaired spermatogenesis and azoospermia.

  • Wen Ming Xu,
  • Jing Chen,
  • Hui Chen,
  • Rui Ying Diao,
  • Kin Lam Fok,
  • Jian Da Dong,
  • Ting Ting Sun,
  • Wen Ying Chen,
  • Mei Kuen Yu,
  • Xiao Hu Zhang,
  • Lai Ling Tsang,
  • Ann Lau,
  • Qi Xian Shi,
  • Qing Hua Shi,
  • Ping Bo Huang,
  • Hsiao Chang Chan

DOI
https://doi.org/10.1371/journal.pone.0019120
Journal volume & issue
Vol. 6, no. 5
p. e19120

Abstract

Read online

Cystic fibrosis (CF) is the most common life-limiting recessive genetic disease among Caucasians caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) with over 95% male patients infertile. However, whether CFTR mutations could affect spermatogenesis and result in azoospermia remains an open question. Here we report compromised spermatogenesis, with significantly reduced testicular weight and sperm count, and decreased cAMP-responsive element binding protein (CREB) expression in the testes of CFTR knockout mice. The involvement of CFTR in HCO(3) (-) transport and the expression of the HCO(3) (-) sensor, soluble adenylyl cyclase (sAC), are demonstrated for the first time in the primary culture of rat Sertoli cells. Inhibition of CFTR or depletion of HCO(3) (-) could reduce FSH-stimulated, sAC-dependent cAMP production and phosphorylation of CREB, the key transcription factor in spermatogenesis. Decreased CFTR and CREB expression are also observed in human testes with azoospermia. The present study reveals a previously undefined role of CFTR and sAC in regulating the cAMP-CREB signaling pathway in Sertoli cells, defect of which may result in impaired spermatogenesis and azoospermia. Altered CFTR-sAC-cAMP-CREB functional loop may also underline the pathogenesis of various CF-related diseases.